Statistics show that obstructive sleep apnea (OSA) is a common disorder affecting around 30 million adults in the US. In a recent press release, the American Food and Drug Administration has ...

Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Sleep apnea is a condition that causes repeated cycles of breathing interruptions during sleep. If left untreated, sleep apnea may lead to dangerous health complications related to oxygen deprivation.

Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in Otolaryngology–Head and Neck Surgery reveals that for people with sleep apnea, ...

Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in ...

Continuous positive airway pressure (CPAP) therapy, which is the most common treatment for obstructive sleep apnea (OSA), may ...

The pathophysiology of residual sleepiness in treated obstructive sleep apnoea (OSA) remains poorly understood. Animal models ...

Sleep apnea involves repeated breathing interruptions during sleep, while loud snoring is steady and doesn’t typically affect breathing. A doctor can help confirm the difference. Sleep apnea is ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.